Stryker Corporation

353.31
3.03 (0.87%)
At close: Apr 14, 2025, 3:13 PM
0.87%
Bid 353.06
Market Cap 134.85B
Revenue (ttm) 22.59B
Net Income (ttm) 2.99B
EPS (ttm) 7.78
PE Ratio (ttm) 45.41
Forward PE 26.35
Analyst Buy
Ask 353.58
Volume 854,888
Avg. Volume (20D) 1,664,040
Open 354.75
Previous Close 350.28
Day's Range 349.14 - 358.00
52-Week Range 314.93 - 406.19
Beta 0.94

About SYK

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and...

Sector Healthcare
IPO Date Mar 17, 1980
Employees 53,000
Stock Exchange NYSE
Ticker Symbol SYK
Full Company Profile

Analyst Forecast

According to 19 analyst ratings, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $431, which is an increase of 21.99% from the latest price.

Stock Forecasts

Next Earnings Release

Stryker Corporation is scheduled to release its earnings on May 1, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-1.19%
Stryker shares are trading lower following Q4 fina... Unlock content with Pro Subscription
2 months ago
+3.24%
Stryker shares are trading higher after the company announced it's commencing a tender offer to acquire the outstanding stock of Inari Medical for $80 per share in cash.